Molecular mechanisms of immunogenic cell death and tumor-specific immune activation via unfolded protein response (UPR) activation by anticancer drugs

Molecular mechanisms of immunogenic cell death and tumor-specific immune activation via unfolded protein response (UPR) activation by anticancer drugs. When anticancer drugs are administered, cancer cells exceed the UPR threshold to the point of lethality, activating the double-stranded RNA-activated protein kinase-like ER kinase (PERK) and inositol-requiring 1 (IRE1) signaling pathways and activating transcription factor 4 (ATF4) and growth arrest- and DNA damage-inducible gene 153 (Gadd153)/CCAAT/enhancer-binding protein homologous protein (CHOP) induction, which in turn downregulates X-linked inhibitor of apoptotic protein (XIAP), decreasing antiapoptotic and increasing proapoptotic B-cell lymphoma 2 (Bcl-2) protein expression, leading to cell death. In this process, dying cancer cells externalize calreticulin (CRT) to the membrane surface and release damage-associated molecular patterns (DAMPs) such as ATP, annexin 1, and high mobility group box 1 (HMGB1) for immune activation. Dendritic cells (DCs) are recruited and activated by the secretion of ATP that binds to P2RY2 and P2RX7 receptors. They are then homed by the binding of released annexin 1 to formyl peptide receptor 1 (FPR1). CRT stimulates the phagocytosis of dying cancer cells by binding to CD91 receptors on DCs. HMGB1 release stimulates DC recruitment via binding to receptor for advanced glycation end products (RAGE) receptors and induces DC maturation via toll-like receptor 4 (TLR4) signaling. Mature DCs migrate to lymph nodes, where they cross-prime and cause the clonal expansion of T cells, including interleukin 12 (IL-12) and type I interferon (IFN). IFN-γ-producing T cells are recruited and exert cytotoxic responses to eradicate cancer cells. Tumor antigens (TAs) released from dying cells are taken up by immature DCs, which then activate and mature. TAs and tumor-associated antigens (TAAs) are processed in mature DCs and presented to CD8+ T cells as major histocompatibility complex I (MHC I) molecules, generating cytotoxic T lymphocytes (CTLs) for tumor-specific immune responses. This figure was custom-made by Wiley Editing Services based on our freehand drawing
Molecular mechanisms of immunogenic cell death and tumor-specific immune activation via unfolded protein response (UPR) activation by anticancer drugs

Publication

Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy (2024) Ryungsa Kim, et al. Cancers (Basel). 2024 Mar;16(5). Figure: F5.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates PERK PERK ncbigene_synonym EIF2AK3 9451
Homo sapiens Primates ATF4 ATF4 ncbigene_symbol ATF4 468
Homo sapiens Primates XIAP XIAP ncbigene_symbol XIAP 331
Homo sapiens Primates Gadd153 GADD153 ncbigene_synonym DDIT3 1649
Homo sapiens Primates Bcl-2 BCL-2 ncbigene_synonym BCL2 596
Homo sapiens Primates IRE1 IRE1 ncbigene_synonym ERN1 2081
Homo sapiens Primates JNK JNK ncbigene_synonym MAPK8 5599
Homo sapiens Primates JNK JNK famplex_relations MAPK9 5601
Homo sapiens Primates JNK JNK famplex_relations MAPK10 5602
Homo sapiens Primates ATP ATP ncbigene_synonym ATP8A2 51761
Homo sapiens Primates P2RX7 P2RX7 ncbigene_symbol P2RX7 5027
Homo sapiens Primates P2RY2 P2RY2 ncbigene_symbol P2RY2 5029
Homo sapiens Primates HMGB1 HMGB1 ncbigene_symbol HMGB1 3146
Homo sapiens Primates CRT CRT ncbigene_synonym CALCR 799
Homo sapiens Primates CRT CRT ncbigene_synonym CALR 811
Homo sapiens Primates CRT CRT ncbigene_synonym SLC6A8 6535
Homo sapiens Primates TLR4 TLR4 ncbigene_symbol TLR4 7099
Homo sapiens Primates RAGE/TLR4 RAGE ncbigene_synonym AGER 177
Homo sapiens Primates RAGE/TLR4 RAGE ncbigene_synonym MOK 5891
Homo sapiens Primates FPR1 FPR1 ncbigene_symbol FPR1 2357
Homo sapiens Primates CD91 CD91 ncbigene_synonym LRP1 4035
Homo sapiens Primates IFNY IFNG ncbigene_symbol IFNG 3458
Homo sapiens Primates IL-12 IL12 famplex_relations IL12A 3592
Homo sapiens Primates IL-12 IL12 famplex_relations IL12B 3593

Chemical mentions

Word Match MeSH Name ChEBI
drugs drugs chebi:23888
PERK PERK tetrachloroethene chebi:17300
ATP ATP ATP chebi:30616

Disease mentions

Word Match MeSH Name DOID
Cancer cancer cancer DOID:162
cancer cancer cancer DOID:162
Cancer cancer cancer DOID:162